Perspective Therapeutics (Acquired) Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 80

Employees

  • Latest Deal Type
  • M&A

Perspective Therapeutics (Acquired) General Information

Description

Developer of a radiopharmaceutical company intended to treat cancer. The company's pipeline of oncology therapeutics, diagnostic imaging agents, and lead (Pb)-212-based alpha-particle radiotherapies are designed to deliver powerful alpha radiation specifically to cancer cells with specialized targeting peptides, enabling health professionals to utilize the same targeting peptide for the purpose of personalizing treatment and optimizing patient outcomes.

Contact Information

Formerly Known As
Viewpoint Molecular Targeting
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Parent Company
Corporate Office
  • 2401 Elliott Avenue
  • Suite 320
  • Seattle, WA 98121
  • United States
+1 (206) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Perspective Therapeutics (Acquired) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Merger/Acquisition 07-Feb-2023 000.00 Completed Clinical Trials - Phase 1
10. Grant 31-Aug-2022 000 000.00 Completed Generating Revenue
9. Later Stage VC (Series A) 14-Jan-2021 000.00 000.00 Completed Generating Revenue
7. Grant 07-Sep-2020 00.000 Completed Generating Revenue
5. Grant 20-Sep-2019 00.000 Completed Generating Revenue
3. Grant 08-Sep-2017 000 Completed Generating Revenue
2. Grant 19-Jan-2017 $1.02M Completed Startup
1. Grant 31-Aug-2016 $1.2M Completed Startup
To view Perspective Therapeutics (Acquired)’s complete valuation and funding history, request access »

Perspective Therapeutics (Acquired) Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a radiopharmaceutical company intended to treat cancer. The company's pipeline of oncology therapeutics, di
Drug Discovery
Seattle, WA
80 As of 2023
000.00
000000&0 000.00

000000

uis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu f
0000 000000000
Houston, TX
00 As of 0000
000.00
00000000000 000.00

000000

eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim ven
0000000000000
Hayward, CA
000 As of 0000
00000
00.000 0000-00-00
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Perspective Therapeutics (Acquired) Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
RadioMedix Venture Capital-Backed Houston, TX 00 000.00 00000000000 000.00
RefleXion (Biotechnology) Venture Capital-Backed Hayward, CA 000 00000 00000000000 00000
Perspective Therapeutics Formerly VC-backed Seattle, WA 000 00000 000000000 00000
You’re viewing 3 of 3 competitors. Get the full list »

Perspective Therapeutics (Acquired) Patents

Perspective Therapeutics (Acquired) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240091705-A1 Removal of free-unlabeled cationic and anionic solution phase radionuclides from radiopharmaceuticals using solid-phase extraction techniques Pending 16-Sep-2022 000000000

Perspective Therapeutics (Acquired) Executive Team (8)

Name Title Board Seat Contact Info
Frances Johnson MD Co-Founder, Chief Innovation Officer & Board Member
Lisa Lauer Vice President of Business Development
Michael Schultz Ph.D Co-Founder, Chief Science Officer & Board Member
Thijs Spoor Chief Executive Officer & Board Member
Amos Hedt Chief Business Strategy Officer
You’re viewing 5 of 8 executive team members. Get the full list »

Perspective Therapeutics (Acquired) Board Members (10)

Name Representing Role Since
Cameron Gray Ph.D Self Board Member 000 0000
Charles Link Jr. Self Board Member 000 0000
Curtis Nelson Self Chairman 000 0000
Frances Johnson MD Perspective Therapeutics (Acquired) Co-Founder, Chief Innovation Officer & Board Member 000 0000
Frank Morich Ph.D Self Board Member 000 0000
You’re viewing 5 of 10 board members. Get the full list »

Perspective Therapeutics (Acquired) Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Perspective Therapeutics (Acquired) Former Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Iowa Economic Development Authority Government 000 0000 000000 0
Iowa Seed Fund Venture Capital Minority 000 0000 000000 0
NIH Seed Not-For-Profit Venture Capital 000 0000 000000 0
National Cancer Institute Government 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »

Perspective Therapeutics (Acquired) Subsidiaries (1)

Company Name Industry Location Founded
Isoray Medical (Brachytherapy Business Division) Drug Discovery Coralville, IA
To view Perspective Therapeutics (Acquired)’s complete subsidiaries history, request access »

Perspective Therapeutics (Acquired) FAQs

  • When was Perspective Therapeutics (Acquired) founded?

    Perspective Therapeutics (Acquired) was founded in 2015.

  • Who is the founder of Perspective Therapeutics (Acquired)?

    Heyward Coleman, Frances Johnson MD, and Michael Schultz Ph.D are the founders of Perspective Therapeutics (Acquired).

  • Who is the CEO of Perspective Therapeutics (Acquired)?

    Thijs Spoor is the CEO of Perspective Therapeutics (Acquired).

  • Where is Perspective Therapeutics (Acquired) headquartered?

    Perspective Therapeutics (Acquired) is headquartered in Seattle, WA.

  • What is the size of Perspective Therapeutics (Acquired)?

    Perspective Therapeutics (Acquired) has 80 total employees.

  • What industry is Perspective Therapeutics (Acquired) in?

    Perspective Therapeutics (Acquired)’s primary industry is Drug Discovery.

  • Is Perspective Therapeutics (Acquired) a private or public company?

    Perspective Therapeutics (Acquired) is a Private company.

  • What is Perspective Therapeutics (Acquired)’s current revenue?

    The current revenue for Perspective Therapeutics (Acquired) is 000000.

  • How much funding has Perspective Therapeutics (Acquired) raised over time?

    Perspective Therapeutics (Acquired) has raised $14.3M.

  • Who are Perspective Therapeutics (Acquired)’s investors?

    Iowa Economic Development Authority, Iowa Seed Fund, NIH Seed, National Cancer Institute, and National Institutes of Health are 5 of 8 investors who have invested in Perspective Therapeutics (Acquired).

  • Who are Perspective Therapeutics (Acquired)’s competitors?

    RadioMedix, RefleXion (Biotechnology), and Perspective Therapeutics are competitors of Perspective Therapeutics (Acquired).

  • When was Perspective Therapeutics (Acquired) acquired?

    Perspective Therapeutics (Acquired) was acquired on 07-Feb-2023.

  • Who acquired Perspective Therapeutics (Acquired)?

    Perspective Therapeutics (Acquired) was acquired by Perspective Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »